6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
20 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Phelinun | Melphalan | EU (EMA) | Authorised | 2020 |
| PHELINUN 200 mg poeder en oplosmiddel voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Melphalan | Netherlands | Authorised | 2020 |
| PHELINUN 50 mg poeder en oplosmiddel voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Melphalan | Netherlands | Authorised | 2020 |
| TEPADINA200 mg / bag ยท Powder For Solution | Thiotepa | Canada | Authorised | |
| TEPADINA15 mg / vial ยท Powder For Solution | Thiotepa | Canada | Marketed | 2017 |
| TEPADINA100 mg / vial ยท Powder For Solution | Thiotepa | Canada | Marketed | 2017 |
| Tepadina | Thiotepa | EU (EMA) | Authorised | 2010 |
| TEPADINA400 mg / bag ยท Powder For Solution | Thiotepa | Canada | Not marketed | 2025 |
| TEPADINA100mg/vial | 15mg/vial ยท Powder | Thiotepa | United States | Marketed | 2017 |
| Tepadina 100 mg, poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Thiotepa | Netherlands | Authorised | 2010 |
| TEPADINA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION100 mg ยท Polvo para concentrado para soluciรณn para perfusiรณn | Thiotepa | Spain | Marketed | 2010 |
| Tepadina 15 mg, poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Thiotepa | Netherlands | Authorised | 2010 |
| TEPADINA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION15 mg ยท Polvo para concentrado para soluciรณn para perfusiรณn | Thiotepa | Spain | Marketed | 2010 |
| Tepadina 200 mg poeder en oplosmiddel voor oplossing voor infusiePoeder en oplosmiddel voor oplossing voor infusie | Thiotepa | Netherlands | Authorised | 2024 |
| Tepadina 400 mg poeder en oplosmiddel voor oplossing voor infusiePoeder en oplosmiddel voor oplossing voor infusie | Thiotepa | Netherlands | Authorised | 2010 |
| TEPADINA 400 mg POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION400 mg ยท Polvo y disolvente para soluciรณn para perfusiรณn | Thiotepa | Spain | Authorised | 2021 |
| TEPADINA AND SODIUM CHLORIDE200mg | 400mg ยท Powder | Thiotepa | United States | Marketed | 2017 |
| Begedina | Begelomab | EU (EMA) | Refused | |
| TEPADINA 100mg100mg ยท Pulb. pt. conc. pt. sol. perf. | Thiotepa | Romania | unknown | |
| TEPADINA 15mg15mg ยท Pulb. pt. conc. pt. sol. perf. | Thiotepa | Romania | unknown |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 6 | 6 | 0 | CompaniesAll medicines |
| Canada | 4 | 4 | 0 | CompaniesAll medicines |
| Spain | 3 | 3 | 0 | CompaniesAll medicines |
| European Union (EMA) | 3 | 2 | 1 | CompaniesAll medicines |
| Romania | 2 | 0 | 2 | CompaniesAll medicines |
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, France, Italy, Malaysia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods JanuaryโSeptember 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep Adienneโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
